Connect with us

Technology

Alethios Unveils a Comprehensive Decentralized Data Collection Suite for Human Health Research

Published

on

Live, no-code integrations let researchers combine participant-reported outcomes, wearables and sensors, AI-powered digital biomarkers, and at-home lab tests in a single study at a fraction of the cost of traditional research.

SAN FRANCISCO, Oct. 22, 2026 /PRNewswire/ — Alethios, the software platform delivering research infrastructure for human health, today launched a comprehensive suite of decentralized data collection tools. Researchers can now combine participant-reported outcomes, wearable and sensor data, digital biomarkers, and at-home biomarker testing in a single study, without writing code, managing multiple vendors, or requiring clinic visits.

Alethios powers studies across nutraceuticals, functional foods, academia, consumer health, medical devices, biotech, and the life sciences. Study designs range from consumer perception studies to pivotal, randomized, double-blind, placebo-controlled trials all run on the same software platform. Customers  including Givaudan, Thorne, PLT Health Solutions, Applied Food Sciences, Hofseth BioCare, Helaina, Samphire Neuroscience, and Sonoran University use the platform to generate rigorous evidence from participants’ homes. The new integrations build on the company’s founding belief that rigorous, multimodal research should be within reach for teams of every size and budget, across the human health ecosystem.

The suite spans four layers of data, each available as a no-code integration within the Alethios Study Planner and Study Operator:

Reported data: participant-submitted photo, video, audio, and text, plus a library of clinically validated instruments, both publicly available and licensed.Generated health data: personal wearables and health platforms including Apple Watch, Google Health, Garmin, Oura, Whoop, and Fitbit, and sensors including Abbott’s continuous glucose monitors and Withings and InBody bioimpedance scales.Digital biomarkers: validated cognitive batteries powered by BrainHQ, skin health selfies for dermatology and cosmetic studies powered by Haut.ai, and 3D body composition scans powered by Prism Labs.At-home biomarker testing: dried blood spot cards, Tasso blood collection devices, and at-home microbiome kits. Standard panels, including male and female hormones, cardiovascular, metabolic, inflammation, vitamin D, and hydration, run through Choose Health. Next-generation tests include epigenetic clocks from Muhdo and TruDiagnostic, and gut and vaginal microbiome sequencing from GutID and other shotgun metagenomic sequencing partners.

Adding a data type takes a few clicks. In the Study Planner, researchers select the data types their study needs and place each one on the participant schedule. For at-home kits, Alethios can handle ordering, shipping, and unique ID verification to keep every sample matched with the right participant, and results flow back into the platform. Once a study is live, the Study Operator brings every data stream into one real-time monitoring dashboard.

Compliant Data Collection by Default

Every integration runs on the platform’s existing infrastructure, where validation and data integrity assurances are built in and each one is designed to encourage participant adherence without compromising data quality. Researchers can:

Schedule each integration on the study timeline, so every data point is accurately time-stamped.Tie completion and compliance to milestone-based tracking and compensation, for example releasing a $50 gift card once a participant’s kit is accessioned at the lab.Monitor adherence across multiple data types in real-time from the Study Operator, so missed wearable syncs, late surveys, or unreturned kits are caught before they turn into missing data.

Every data point is cleaned and aligned to its participant automatically, so research teams receive one analysis-ready dataset rather than stitching together exports from multiple vendors.

“We built Alethios for researchers across human health,” said Zeenia Framroze, Founder and CEO of Alethios. “There are so many new ways to collect data at home, and we want to give research teams the best of them, wherever they sit. Whether someone is designing a claims substantiation study for a supplement or running post-marketing surveillance for a drug, we want to make it easy to collect robust subjective and objective data from Alethiad participants around the nation. The better and more accessible data collection is, the more we move the needle on our understanding of all of human health.”

A Home for Next-Generation Health Measurement

“So many novel devices and at-home tests are being developed today,” said Gurpreet Atwal, CTO of Alethios. “We want Alethios to be the tool scientists and innovators use to rapidly develop and validate new methods of data collection, and the home for the newest, best-in-class technologies for measuring human health. With rapid recruitment through the Alethiad Participant Community, those technologies can be tested with diverse, representative participants from day one.”

Companies developing novel devices, tests, or digital biomarkers can apply to integrate with Alethios here.

About Alethios

Alethios is a software platform delivering research infrastructure for human health. Its AI-powered, full-stack software delivers the capabilities of a study team without the overhead. The platform unifies protocol design, IRB coordination, recruitment, participant management, multimodal data collection, and reporting for decentralized clinical trials. Principal investigators, sponsors, and CROs rely on Alethios to generate rigorous real-world evidence across human health industries, setting up a study in minutes with plans starting at $100 per month. Through the Study Planner, Study Operator, and the Alethiad Participant Community, research teams can use the software in a self-service, hybrid, or fully turn-key model, at a fraction of the cost of traditional research.Alethios is a 2026 Nutra Healthspan Innovator Award winner, a 2026 Vitafoods Europe Startup Challenge finalist, and a 2025 NutraIngredients-USA Startup Award finalist. Get started at Alethios.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/alethios-unveils-a-comprehensive-decentralized-data-collection-suite-for-human-health-research-302916518.html

SOURCE Alethios, Inc.

Continue Reading

Technology

Chelsea FC announces multi-year sleeve partnership with Sokin, the business payments and FX platform

Published

on

By

Chelsea FC name fast-growing fintech platform as Principal Partner

LONDON, Oct. 23, 2026 /PRNewswire/ — Chelsea Football Club has today announced a multi-year partnership with Sokin, the embedded finance and payments company used by businesses worldwide. Sokin will be named a Principal Partner and Official Business Payments and FX Partner of Chelsea FC and Chelsea FC Women.

As a Principal Partner, Sokin will be represented on the sleeves of the Chelsea FC men’s, women’s and academy home, away, and third kits from the 2026/27 season.

The partnership brings together two ambitious London-headquartered organisations with worldwide reach – a club with millions of fans across the world and a fintech platform through which businesses move more than $11 billion a year. A club of Chelsea’s scale works in many currencies every day, with partners, competitions and supporters around the world, and needs a financial partner built to handle that.

Sokin gives finance teams business payments, multi-currency accounts, foreign exchange, checkout and treasury in one place, so they spend less time juggling banks and providers and keep more of what they move.

As Official Business Payments and FX Partner, Sokin will simplify how Chelsea FC sends, receives and manages money in the currencies the club operates in.

The Sokin logo will feature on the sleeve of the Chelsea shirt for the first time [when the men’s team host Tottenham Hotspur at Stamford Bridge on Saturday 24th October.]

Jason Gannon, President at Chelsea FC said:

“At Chelsea, we seek to partner with organisations that share our ambition and innovative mindset. Sokin’s expertise in business payments, and their focus on making both simpler for the businesses they serve, makes them a natural fit for the Club. We are pleased to welcome Sokin to the Chelsea family and look forward to working together in the years ahead.”

Vroon Modgill, CEO and founder at Sokin said:

“Chelsea plays on the biggest stage in world football, and its business runs in dozens of currencies. Sokin was built for that with regulated, multi-currency payments and foreign exchange for organisations that operate internationally. We’re proud to be the platform behind the business payments and FX of one of the most iconic teams in football. Sokin’s platform serves businesses in more than 170 countries. We’re thrilled to be partners for the season ahead. An organisation as sophisticated as Chelsea doesn’t leave its finances to chance.”

About Sokin

Sokin is the financial layer global business runs on. Businesses can transact, convert and hold money in 70+ currencies across 170+ countries. Some businesses use Sokin to manage global finance in-house. Others build it into their products to power financial experiences for their customers. Businesses move more than $9 billion a year on licenses Sokin holds in 36+ countries and infrastructure Sokin owns. Founded in 2019, Sokin has raised over $100 million from investors including Morgan Stanley Expansion Capital and Prysm Capital.

About Chelsea Football Club

Chelsea Football Club is one of the biggest, most successful football clubs globally and our men’s team are reigning world champions, having won the four-yearly FIFA Club World Cup in 2025. Our women’s team, Chelsea Women, are also multiple trophy winners.

Founded in 1905, Chelsea is London’s most central football club, based at the iconic 40,000-capacity Stamford Bridge stadium. Nicknamed the Blues, the club lifted the Champions League for the first time in 2012 and domestically has won the Premier League five times, the FA Cup eight times, the Football League Cup five times and the Football League Championship once, in 1955.

The Chelsea Women’s team have enjoyed a huge amount of success and in 2025 won the FA Women’s Super League for a sixth consecutive year and the eighth time overall. The Women’s FA Cup has been won on six occasions. We have also captured the FA Women’s League Cup four times as well as reaching the UEFA Women’s Champions League final in 2021. In two seasons, 2020/21 and 2024/25, a domestic treble of trophies was secured.

The Chelsea Foundation boasts one of the most extensive community initiatives in sport, helping to improve the lives of children and young people all over the world.

Media Contacts:

Taina Biggs
taina.biggs@sokin.com 

Nerissa Chesterfield
nerissa.chesterfield@chelseafc.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/chelsea-fc-announces-multi-year-sleeve-partnership-with-sokin-the-business-payments-and-fx-platform-302918466.html

Continue Reading

Technology

Amy Johnson Appointed President of GDIT

Published

on

By

RESTON, Va., Oct. 23, 2026 /PRNewswire/ — General Dynamics (NYSE:GD) announced today that Amy Johnson has been appointed as president of GDIT, effective November 3.

Johnson is a 27-year veteran of General Dynamics Mission Systems, where she held increasingly senior roles in engineering, engineering management and business leadership across cybersecurity, defense electronics, space and intelligence systems, most recently as vice president and general manager for Space, Cyber and Intelligence. She earned bachelor’s and master’s degrees in computer science and computer systems engineering. 

“Amy has a proven track record of leading teams to solve complex and highly technical challenges for our customers,” said Phebe Novakovic, CEO of General Dynamics. “I am confident that her dynamic leadership, operational rigor and deep commitment to our values and culture will deliver value to our customers, employees and shareholders.”

GDIT delivers digital modernization, cloud computing, artificial intelligence, cybersecurity and software development solutions to the U.S. federal government, defense, intelligence agencies and other customers. It is a business unit of General Dynamics, a global aerospace and defense company that offers a broad portfolio of products and services in business aviation; ship construction and repair; land combat vehicles, weapons systems and munitions; and technology products and services. General Dynamics employs more than 120,000 people worldwide and generated $52.6 billion in revenue in 2025. More information is available at gd.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/amy-johnson-appointed-president-of-gdit-302918411.html

SOURCE General Dynamics

Continue Reading

Technology

Yazan Al Homsi Invests US$500,000 in Toronto Drone Maker Arcanus Aerial Systems

Published

on

By

Private investment comes as Arcanus builds out Canadian manufacturing capacity for autonomous aerial systems

DUBAI, UAE, Oct. 23, 2026 /PRNewswire/ — Yazan Al Homsi, a UAE-based investor and managing partner of Catalyst Communications DMCC, has invested US$500,000 in Arcanus Aerial Systems Inc., a Toronto-headquartered developer and manufacturer of unmanned aerial systems for defence, public safety and critical infrastructure customers. Al Homsi is an investor only and holds no operational, advisory or board role with the company. Other terms were not disclosed.

Arcanus is a Canadian-controlled company. It currently lists more than 15 platforms across heavy-lift, intelligence, surveillance and reconnaissance (ISR), cargo, strike and counter-drone missions. According to the company, its published line-up includes:

AB 516e: a long-endurance vertical take-off fixed-wing aircraft rated for three hours of flight.AE 401: a counter-drone interceptor with a top speed of 300 km/h.AC 5250: a cargo platform with a 250 kg payload and a range of more than 2,300 km.

Alongside defence, Arcanus markets its systems for wildfire detection, search and rescue, Arctic sovereignty, border and maritime patrol, and pipeline and power line monitoring.

The company has spent 2026 assembling its domestic production base. In April, Arcanus signed a binding term sheet with Portugal-based Beyond Vision, granting it rights to manufacture, commercialize and support Beyond Vision’s unmanned aerial systems in Canada.

In June, Arcanus announced a five-year agreement appointing FeralX Systems Inc. as a non-exclusive Canadian contract manufacturer for several of its platforms.

“Canada has the engineering talent to build these systems at home, and recent years have shown how much depends on having that capacity domestically,” said Yazan Al Homsi. “What stood out to me about Arcanus was the manufacturing groundwork already in place: licensing, a production partner, and a range of aircraft that serves wildfire crews and search-and-rescue teams alongside defence customers.”

About Yazan Al Homsi

Yazan Al Homsi is a UAE-based investor and managing partner of Catalyst Communications DMCC, which he founded in Dubai in 2018. He was previously based in Vancouver, where he founded Founders Round Capital in 2017 and built a track record of investments in early-stage and small-cap companies. He earned a finance degree from McGill University in 2004 and holds the Chartered Financial Analyst designation. Before turning to investing, he spent more than a decade with PricewaterhouseCoopers in the Middle East, rising to director and focusing on transaction due diligence and valuation.

Media Contact
Catalyst Communications DMCC
catalyst-wire@protonmail.com

View original content:https://www.prnewswire.com/news-releases/yazan-al-homsi-invests-us500-000-in-toronto-drone-maker-arcanus-aerial-systems-302918414.html

SOURCE Yazan Al Homsi

Continue Reading

Trending